1.
The assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1). Journal of Pharmaceutical Negative Results [Internet]. 2022 Jan. 30 [cited 2026 Jun. 4];13(1):39-43. Available from: https://www.pnrjournal.com/index.php/home/article/view/180